Novocure Ltd (NASDAQ:NVCR)

78.23
Delayed Data
As of 3:59pm ET
 +0.82 / +1.06%
Today’s Change
53.40
Today|||52-Week Range
98.84
-7.17%
Year-to-Date
NovoCure (NVCR) Q2 2020 Earnings Call Transcript
Jul 30 / MotleyFool.com - Paid Partner Content
Notable earnings before Thursday's open
Jul 29 / Seeking Alpha - Paid Partner Content
NovoCure Limited (NVCR) CEO Asaf Danziger on Q2 2020 Results - Earnings Call Transcript
Jul 30 / Seeking Alpha - Paid Partner Content
Notable earnings before Thursday's open
Jul 29 / Seeking Alpha - Paid Partner Content
NovoCure Limited 2020 Q2 - Results - Earnings Call Presentation
Jul 30 / Seeking Alpha - Paid Partner Content
XBiotech Breakthrough, And Other News: The Good, Bad And Ugly Of Biopharma
Jul 25 / Seeking Alpha - Paid Partner Content
NovoCure EPS beats by $0.02, beats on revenue
Jul 30 / Seeking Alpha - Paid Partner Content
3 Great Healthcare Stocks to Watch
Jul 24 / MotleyFool.com - Paid Partner Content
NovoCure Q2 2020 Earnings Preview
Jul 29 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close77.41
Today’s open77.14
Day’s range77.01 - 78.80
Volume44,142
Average volume (3 months)975,784
Market cap$7.7B
Data as of 3:59pm ET, 08/04/2020

Growth & Valuation

Earnings growth (last year)+89.25%
Earnings growth (this year)+341.07%
Earnings growth (next 5 years)+60.00%
Revenue growth (last year)+41.62%
P/E ratio651.9
Price/Sales23.32
Price/Book34.64

Competitors

 Today’s
change
Today’s
% change
TNDMTandem Diabetes Care...+0.31+0.29%
NVRONevro Corp-3.91-2.87%
MASIMasimo Corp-1.15-0.53%
IRTCiRhythm Technologies...+35.17+27.62%
Data as of 4:42pm ET, 08/04/2020

Financials

Next reporting dateOctober 28, 2020
EPS forecast (this quarter)$0.05
Annual revenue (last year)$351.3M
Annual profit (last year)-$7.2M
Net profit margin-2.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
St. Helier, Jersey

Forecasts